Disease Progression
24
0
3
14
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
3 terminated out of 24 trials
82.4%
-4.2% vs benchmark
13%
3 trials in Phase 3/4
29%
4 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (24)
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
Virta Health Registry
Treatment Resistance Following Anti-cancer Therapies
Natural Disease Progress of Dupuytren Disease
Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission
Biomarkers and Mechanisms of Disease Progression and Outcome of Aortic Stenosis in Humans
Predicting Disease Progression and/or Recurrence in Cancer
A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR
Salvage Surgery for Patients With Metastatic GIST With Rego
Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN
Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home Telemonitoring
Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease
Efficacy Study of Water Drinking on PKD Progression.
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department
Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?